Alan Milinazzo is joining Opsens as the chairman of its board of directors and brings with him experience in leading global businesses, as well as his expertise in driving adoption of new technologies for interventional cardiology, spine, and surgical products.

A partner at Heidrick & Struggles in Boston and a member of the Global Healthcare and Life Sciences Practice specializing in the medical device sector, Milinazzo was also chief executive officer of InspireMD, a pioneer in embolic prevention systems (EPS) for coronary and vascular applications.

Milinazzo previously served as president and chief executive officer of Orthofix International NV, a $600 million publicly traded global orthopedic and spine company, as well as general manager of Medtronic Inc.’s coronary and peripheral vascular businesses where he was instrumental in the development and commercialization of several key products, including the company’s first coronary drug-coated stent platform.

In addition, Milinazzo spent 12 years with Boston Scientific in multiple global sales and marketing leadership roles during a period of unprecedented top-line growth in the cardiology franchise.

Milinazzo currently serves as a director of Flexion Therapeutics and the Musculoskeletal Transplant Foundation. Prior directorships included LDR Spine, Medpace, HET Systems, and LumenR. He earned a bachelor’s degree, cum laude, from Boston College and interned at the White House, the U.S. House of Representatives, and the John F. Kennedy Presidential Library.